CC
The Chemours Company
Specialty Chemicals · Basic Materials · United States
13.19
close · 2026-10-29
value
70
cheaper than peers70
quality
1
stronger fundamentals1
ranked against
Specialty Chemicals
value
quality
42 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 7.10× | 99 |
| price to sales | 0.38× | 94 |
| EV to EBITDA | 11.02× | 57 |
| price to book | 10.20× | 9 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 3.0% | 18 |
| revenue growth | 1.0% | 6 |
| debt to equity | 2033.8% | 4 |
| return on equity | -103.0% | 4 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $216.3M |
| employees | 5,700 |
| first trade | 2015-06-19 |
| next earnings | 2026-11-02 |
| fundamentals updated | 2026-08-05 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.57 | 0.57 | -1.70 | 3.65 |
| free cash flow | $51.0M | -$993.0M | $186.0M | $448.0M |
| net income | -$386.0M | $69.0M | -$253.0M | $578.0M |
| revenue | $5.81B | $5.78B | $6.08B | $6.83B |
| unusual items | -$44.0M | -$109.0M | -$51.0M | -$1.0M |